News tagged with glaxosmithkline
GlaxoSmithKline says annual profits triple to £5.26 bln
British drugmaker GlaxoSmithKline said Tuesday that net profits more than tripled in 2011 compared with the previous year, as large efficiency savings offset falling revenues.
Feb 07, 2012 |
not rated yet |
0
Drug firms sign up to new tropical disease fight
Key players in the pharmaceutical industry pledged on Monday to donate 14 billion drug treatments as part of a new, global push to eradicate tropical diseases.
Jan 30, 2012 |
not rated yet |
0
British drugs firm GSK settles US drug disputes for $3.0 bln
GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.
Medicine & Health / Medications
Nov 03, 2011 |
5 / 5 (1) |
0
Pharma giants open up drug patents in new collaboration
Pharmaceutical giants and the UN intellectual property agency launched Wednesday a collaboration to share certain patented drug information with public organisations.
Medicine & Health / Medications
Oct 26, 2011 |
5 / 5 (1) |
2
GlaxoSmithKline posts rising Q3 profits
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rose seven percent, boosted by growth across its main pharmaceuticals, vaccines and consumer healthcare divisions.
Oct 26, 2011 |
5 / 5 (1) |
1
Drug firm GSK fined $2.6 million for collusion
South Korea's anti-trust agency has fined drugmaker GlaxoSmithKline three billion won ($2.6 million) for conspiring with a Seoul rival over the sale of drugs, an official said Monday.
Medicine & Health / Medications
Oct 24, 2011 |
not rated yet |
0
South Asians and Europeans react differently to common drugs
(Medical Xpress) -- A University of Sydney PhD student has discovered the different diets and lifestyles of South Asians compared to Europeans could lead to the two groups requiring very different doses of medicines commonly ...
Medicine & Health / Medications
Oct 14, 2011 |
3 / 5 (2) |
0
Drugs firm GSK eyes India acquisitions: chief executive
British drugmaker GlaxoSmithKline is in the market to buy assets in India at a total cost of up to $2.0 billion (1.5 billion euros), its chief executive said in an interview published on Monday.
Medicine & Health / Medications
Oct 03, 2011 |
not rated yet |
0
Compound improves health, increases lifespan of obese mice
(Medical Xpress) -- Researchers have reported that obese male mice treated with a synthetic compound called SRT1720 were healthier and lived longer compared to non-treated obese mice. The experimental compound was found to ...
Aug 22, 2011 |
not rated yet |
1
|
GlaxoSmithKline reports return to profit in second quarter
British drugmaker GlaxoSmithKline posted net profit of more than £1.1 billion in the second quarter on Tuesday following a loss during the equivalent three-month period in 2010.
Medicine & Health / Medications
Jul 26, 2011 |
not rated yet |
0
Glaxo pays 41 million to settle US drug quality matter
British pharmaceutical giant GlaxoSmithKline said Thursday it is paying 41 million dollars to settle allegations of poor drug quality at a manufacturing plant in Puerto Rico.
Medicine & Health / Medications
Jun 23, 2011 |
not rated yet |
0
Internet minders OK vast expansion of domain names
Internet minders voted Monday to allow virtually unlimited new domain names based on themes as varied as company brands, entertainment and political causes, in the system's biggest shake-up since it started ...
Jun 20, 2011 |
not rated yet |
1
China orders recall of Glaxco drug
China Saturday ordered British pharmaceutical giant GlaxoSmithKline to recall an antibiotic used to treat infections in children which was found to be tainted with a plasticiser.
Medicine & Health / Medications
Jun 19, 2011 |
5 / 5 (1) |
0
FDA links some prostate drugs to cancer risk
(AP) -- The Food and Drug Administration expanded the warning label on a group of prostate drugs Thursday, saying they may increase the risk of a more serious form of prostate cancer.
Medicine & Health / Medications
Jun 09, 2011 |
3 / 5 (1) |
0
'Walking distance' test an accurate indicator of disease severity in patients with COPD
The six-minute walking distance test (6MWD), a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive ...
May 16, 2011 |
not rated yet |
0
GlaxoSmithKline
GlaxoSmithKline plc (LSE: GSK NYSE: GSK) is a United Kingdom-based pharmaceutical, biological, and healthcare company. GSK is the world's second largest pharmaceutical company and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
For more information about GlaxoSmithKline, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
